Opdivo Precision Cancer Medicine Improves Outcomes in Advanced Liver Cancer

Results from the CheckMate 040 clinical trial have been recently reported and found that Opdivo nivolumab an immuno-oncology drug which acts by modulating the immune system produces durable responses with long-term survival rates in patients with liver ca [...]

Skin Cancer Prevention Tips from the Skin Cancer Foundation

The development of skin cancer is certainly a risk for any individual but particularly for those of us who spend time in the outdoors As summer approaches its important to keep in mind that by taking certain steps to protect yourself from the sun you can [...]

Half of Breast Cancer Patients Pursue Reconstructive Surgery Without Understanding of Risks

More than half of breast cancerpatients 57 percent undergoing mastectomy lack the necessary medical knowledge to make a high-quality decision about reconstructive surgery that aligns with their personal goals suggesting a trend toward overtreatment accord [...]

Avelumab Immunotherapy Approved for Bladder Cancer

Bavencio Avelumab a programmed cell death ligand1 PD L1 inhibitor has been approved for treatment of patients with locally advanced or metastatic urothelial carcinoma whose disease progressed during or following platinum-containing chemotherapy or within [...]

FDA Approval Suggests Keytruda® Combined With Chemotherapy May Become New Standard Initial Treatment for Patients With Metastatic Non-Small Cell Lung Cancer

The US Food and Drug Administration FDA has approved Keytruda pembrolizumab an anti-PD-1 precision cancer medicine in combination with Alimta pemetrexed and carboplatin chemotherapy as first-line treatment of metastatic non-small cell lung cancer NSCLC ir [...]

FDA Approves Imfinzi for Treatment of Urothelial Cancer

The US Food and Drug Administration FDA today granted accelerated approval to Imfinzi durvalumab for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing ch [...]

First New Drug for Liver Cancer in a Decade: Stivarga

The US Food and Drug Administration FDA has expanded the indication for Stivarga regorafenib to now include treatment for patients with hepatocellular carcinoma HCC who have previously been treated with the drug Nexavar Expansion of Stivarga 8216s indicat [...]

Kite Pharma Updates Results of CAR-T cell therapy in Aggressive Non-Hodgkin Lymphoma

Results from the ZUMA-1 trial of axicabtagene ciloleucel KTE-C19 in patients with chemorefractory aggressive non-Hodgkin lymphoma NHL were updated recently at the American Society of Hematology Annual Meeting in San Diego California Overall 76 of patients [...]

Endometriosis Patients are at Increased Risk for Ovarian Cancer, Study Confirms

A large study based on the Nurses Health confirms that endometriosis is associated with increased risk of ovarian cancer Moreover it further clarifies that this condition is not linked to a greater risk for endometrial cancer Many women with endometriosis [...]

Have a Question about Chronic Myeloid Leukemia? Join us on May 25th!

CancerConnect Presents Ask the Expert with Dana-Farber Cancer Institutes Dr Luskin CancerConnect announces the opportunity to engage with leukemia expert Marlise Luskin MD MSCE On May 25th 2017 Dr Luskin will answer your pre-submitted questions about chro [...]